This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Coave Therapeutics. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gaëlle Lefèvre: Innovator in Gene Therapy
Introduction
Gaëlle Lefèvre is a prominent inventor based in Bourg-La-Reine, France. He has made significant contributions to the field of gene therapy, particularly through his innovative work with adeno-associated virus vectors. His expertise and dedication to advancing medical science have led to the development of valuable patents.
Latest Patents
Gaëlle Lefèvre holds a patent for "Lactam-Modified Adeno-Associated Virus Vectors." This patent represents a crucial advancement in the delivery mechanisms of gene therapy, enhancing the efficacy and safety of treatments.
Career Highlights
Throughout his career, Lefèvre has been associated with Coave Therapeutics, a company focused on developing innovative gene therapies. His work has been instrumental in pushing the boundaries of what is possible in the treatment of genetic disorders.
Collaborations
Lefèvre has collaborated with notable colleagues, including Karl Gibson and Nicolas Ferry. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Gaëlle Lefèvre's contributions to gene therapy through his patent and work at Coave Therapeutics highlight his role as a key innovator in the field. His ongoing efforts continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile